Related Experiment Video
Updated: Jul 13, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication
Yuan Li1, Li Ye, Jin-Song Peng
1Division of Allergy and Immunology, Joseph Stokes, Jr., Research Institute, Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Morphine, heroin's active metabolite, hinders interferon-alpha (IFN-alpha) production in liver cells. This inhibition promotes hepatitis C virus (HCV) replication and persistence, highlighting a new mechanism in HCV pathogenesis.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) infection is a significant global health concern, particularly prevalent among individuals who use heroin.
- Chronic HCV infection can lead to severe liver disease, including cirrhosis and hepatocellular carcinoma.
- Understanding factors that influence HCV replication and persistence is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the effect of morphine, the primary active metabolite of heroin, on intrahepatic interferon-alpha (IFN-alpha) expression.
- To determine if morphine influences hepatitis C virus (HCV) replication in human hepatocytes.
- To elucidate the molecular mechanisms by which morphine may affect HCV pathogenesis.
Main Methods:
- Primary human hepatocytes were cultured and treated with morphine.
- HCV replication levels were quantified in the presence and absence of morphine.
- Expression of key interferon regulatory factors (e.g., IFN regulatory factor 5) and signaling molecules (e.g., p38) was assessed using molecular biology techniques.
- The anti-HCV effects of recombinant IFN-alpha were evaluated in the context of morphine treatment.
Main Results:
- Morphine significantly inhibited the expression of intrahepatic IFN-alpha in human hepatocytes.
- This inhibition of IFN-alpha was correlated with an increased rate of HCV replication.
- Morphine exposure diminished the antiviral efficacy of recombinant IFN-alpha against HCV.
- Mechanistically, morphine was found to suppress the expression of IFN regulatory factor 5 and p38 signaling pathways, which are critical for IFN-alpha-mediated antiviral activity.
Conclusions:
- Morphine acts as a cofactor in facilitating HCV persistence within human hepatocytes.
- The drug interferes with the host's innate immune response by downregulating IFN-alpha production and signaling.
- These findings suggest a direct role for heroin's metabolite in exacerbating HCV infection, offering potential targets for therapeutic intervention.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Inhibitors Of Virion Release
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

